Data as of Apr 16
 -0.02 / -1.31%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Cadus Corp. engages in development and application of novel yeast-based and other drug discovery technologies. The company is presently seeking to license the subsidiary's drug discovery technologies and use all or a portion of its existing cash and, where feasible and appropriate, seek additional debt or equity financing, to acquire or invest in one or more companies or income producing assets. Cadus was founded on January 23, 1992 and is headquartered in New York, NY.

Contact Information

Cadus Corp.
767 Fifth Avenue
New York New York 10153-0023
P:(212) 702-4300
Investor Relations:



Individual stakeholders51.79%
Other institutional44.00%
Mutual fund holders3.90%

Top Executives

Hunter Clark GaryPresident, Chief Executive Officer & Director
David BlitzChief Financial Officer, Secretary & Treasurer
James R. BroachDirector & Research Director

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.